NSC2500 Pharmacology Presentation: Cancer Pathophysiology and Drugs
VerifiedAdded on  2022/12/20
|2
|347
|26
Presentation
AI Summary
This presentation provides a comprehensive overview of pharmacology, specifically focusing on cancer treatment. It delves into the pathophysiology of cancer, highlighting the role of factors like insulin and adinopectin in energy balance disruption and the impact of mutations in p53 genes. The presentation details the use of Adriamycin (doxorubicin) as a key drug, its mode of action involving intercalation and topoisomerase inhibition, and its pharmacokinetic properties, including a half-life of 24-48 hours. Furthermore, it acknowledges the drug's side effects and emphasizes the importance of nursing practices, such as formulating care plans and establishing therapeutic relationships, to support patients physically and mentally. The presentation underscores the need for patient-centered care to improve the overall health conditions of women globally. This assignment is designed to improve the knowledge of homeostasis and how disruption may lead to a specific disease or disorder. It also helps students understand how drug therapies address a particular pathophysiology, identify drug mode of action, indications, contraindications, potential interactions, adverse effects and therapeutic outcomes.
1 out of 2







